Balanced product information

Evidence, limitations and safety — in one consistent format.

This page separates authorised uses from investigational or reported uses. It does not provide personal medical advice or dosing instructions.

Last content review12 September 2026
01

Product name

Human chorionic gonadotropin (HCG) 5000 IU / 3 mL

Catalogue formatInjection Pen Kit
Displayed strength5000 IU / 3 mL
UK contextPrescription-only medicine context; HELIX presentation not verified as UK-authorised

Catalogue label details describe what is displayed; they do not independently verify composition, quality, batch release or UK marketing authorisation.

02

What is it?

Human chorionic gonadotropin (HCG) is a hormone that can act similarly to luteinising hormone in the body. Certain HCG medicines are used in specialist fertility and endocrine contexts.

This HELIX catalogue entry describes a 5000 IU / 3 mL labelled presentation and its click-volume reference only. It does not verify composition, sterility, quality, suitability or UK marketing authorisation.

03

Intended / recognised uses

Authorised / recognised uses

  • Specific HCG medicines may be prescribed by specialists for defined fertility or endocrine indications, depending on the licensed product and patient assessment.
  • Use normally requires diagnosis, baseline assessment and professional supervision.

Reported / non-authorised uses

  • Self-directed hormone use, bodybuilding, post-cycle therapy or general performance purposes are not established as authorised uses of this HELIX presentation.
  • The HELIX-labelled HCG 5000 IU presentation has not been verified here as an authorised UK medicine.
04

How it works

HCG can stimulate LH receptors, which may affect testosterone production in males and ovulation-related pathways in females, depending on clinical context.

Hormonal effects vary by diagnosis, dose, schedule and individual health factors.

05

Potential benefits / effects

  • Where clinically indicated and prescribed, HCG may support specific fertility or endocrine treatment goals.
  • Benefits are not guaranteed and depend on diagnosis, monitoring and whether treatment is medically appropriate.
  • The displayed HELIX presentation itself is not evidence of safety, efficacy or regulatory approval.

Potential benefit is not a guarantee of benefit for any individual.

06

Risks & warnings

  • Hormonal treatment can cause unwanted endocrine effects and may worsen some underlying conditions.
  • Unverified injectable products may create risks from contamination, incorrect concentration, storage problems or misuse.
  • A click guide is not a prescribing instruction; dose and schedule must be set and monitored by an appropriately qualified healthcare professional.
07

Possible side effects

Common or recognised effects

  • Injection-site reactions, headache, mood changes, fluid retention or breast tenderness may occur with gonadotropin-type treatment.
  • Side-effect patterns depend on sex, indication, dose and the specific licensed product.

Serious or urgent concerns

  • Severe allergic reaction, significant swelling, severe abdominal pain, chest pain, breathlessness or symptoms of blood clots require urgent medical care.
  • Fertility treatment can require monitoring for ovarian hyperstimulation risk where relevant.
08

Who should not use it / precautions

  • Medical advice is required for hormone-sensitive cancers, unexplained bleeding, ovarian cysts, pituitary or hypothalamic disease, thrombotic risk, pregnancy, breastfeeding or fertility treatment.
  • Do not use any injectable medicine if identity, sterility, expiry, storage or authenticity cannot be verified.
09

Interactions

  • Other fertility medicines, hormones, testosterone, anabolic agents or medicines affecting endocrine function should be reviewed by a clinician or pharmacist.
  • All prescribed medicines, supplements and performance-enhancing substances should be disclosed before any hormonal treatment.
10

Regulatory / legal status

  • HCG medicines are prescription-only in the UK where authorised for specific indications and product presentations.
  • No UK marketing authorisation has been verified here for this HELIX HCG 5000 IU / 3 mL presentation.
  • Displaying the product on this website is educational information only and is not an offer for sale or a recommendation to use it.
11

Monitoring / professional supervision

  • Professional monitoring may include diagnosis confirmation, fertility/endocrine assessment, relevant blood tests and review of adverse effects.
  • Treatment decisions and targets must be set by an appropriately qualified healthcare professional.
11A

Labelled HCG 5000 IU click-volume guide

Clicks1 click
Volume0.01 mL
Amount16 IU
Clicks5 clicks
Volume0.05 mL
Amount80 IU
Clicks10 clicks
Volume0.10 mL
Amount160 IU
Clicks15 clicks
Volume0.15 mL
Amount240 IU
Clicks20 clicks
Volume0.20 mL
Amount320 IU
Clicks25 clicks
Volume0.25 mL
Amount400 IU
Clicks30 clicks
Volume0.30 mL
Amount480 IU
Clicks35 clicks
Volume0.35 mL
Amount560 IU
Clicks40 clicks
Volume0.40 mL
Amount640 IU
Clicks45 clicks
Volume0.45 mL
Amount720 IU
Clicks50 clicks
Volume0.50 mL
Amount800 IU
Clicks55 clicks
Volume0.55 mL
Amount880 IU
Clicks60 clicks
Volume0.60 mL
Amount960 IU
Clicks62.5 clicks
Volume0.625 mL
Amount1000 IU

This table is a labelled pen-volume reference only. It is not personal dosing advice, and medical assessment/professional supervision is required before any use.

12

Evidence & sources

Sources are selected for regulatory status, recognised uses and material safety information. They do not validate the HELIX-labelled presentation.

  1. BNF — Chorionic gonadotrophin
  2. Electronic Medicines Compendium — Search HCG product information
  3. MHRA — Yellow Card adverse-event reporting

Sources accessed and content reviewed 12 September 2026. Regulatory status can change; consult the current official record.

13

Information disclaimer

HELIX — FOR INFORMATION ONLY. NOT FOR SALE.

The products displayed on this website are presented strictly for informational and educational purposes, helping visitors understand their descriptions, features and specifications. No products are offered for sale through this website, and no product orders or payments are accepted through this platform.

The information on this website does not constitute medical advice, a prescription or a recommendation to use any product. Displaying a product does not establish its regulatory approval, safety or suitability for an individual. Please consult an appropriately qualified healthcare professional for personal medical advice.

For a UK-facing website, this disclaimer does not by itself establish legal compliance. Public advertising of prescription-only medicines and advertising of unlicensed medicines are subject to legal restrictions; the catalogue, wording and presentation require appropriate regulatory review.

14

Licensed-provider information

Where permitted by applicable law, HELIX may display contact details for independent third-party providers whose registration details have been checked against an appropriate official register. Visitors may contact a listed provider directly to enquire about lawful availability and eligibility requirements.

Any supply is subject to the provider’s assessment, applicable regulations, and verification of all required documentation, which may include a valid prescription, professional licence, identification or other authorisation. A referral does not guarantee availability, eligibility or supply.

Registration status can change. Review the provider's regulator, registration number, official-register record and last-checked date, then verify the current status independently before engaging.